Medical device and MedTech insights, news, tips and more

State of the Art Proton Therapy Cancer Treatment Saves New Mom’s Eyesight

May 9, 2016

Proton Therapy

Orlando, Fla – An enormous high tech machine is providing new hope to patients across the country with inoperable tumors. Proton therapy is a precise radiation technique that reduces the side effects often accompanied by traditional treatment options. Thanks to this remarkable technology, a new proton therapy center at UF Health Cancer Center – Orlando Health is saving the eyesight of a new mother who was diagnosed with a tumor behind her eye during her second trimester of pregnancy.

Proton TherapyRhea Birusingh, 37, began experiencing blurry vision and thought it was due to her pregnancy. But when she went to see her opthamologist, she was diagnosed with a benign brain tumor located behind her right eye, which was feeding on the same hormones associated with her pregnancy. Because of the tumor’s placement it was deemed inoperable, and without proton therapy, Rhea would face declining memory and loss of her eyesight.

“Unfortunately, even with just one scan, we knew the tumor was in the worst location possible,” said Birusingh.

In order to treat the tumor, Rhea was induced at 34 weeks, and became the first patient to be treated with proton beam therapy at the new Marjorie and Leonard Williams Center for Proton Therapy at Orlando Health. There, doctors used a massive, 3-story, 200,000 pound machine to direct a proton beam into an area of Rhea’s brain less than a millimeter in diameter.

“This machine is extremely powerful and incredibly accurate,” said Dr. Naren Ramakrishna, the director of proton therapy at UF Health Cancer Center – Orlando Health “Proton therapy allowed us to treat Rhea’s tumor successfully while minimizing the dose to the very critical surrounding structures. In her case these structures included areas of the brain, the optic nerves and the pituitary gland.”

Read More – Source: Breakthrough technology offers new treatment for patients with hard-to-reach tumors | EurekAlert! Science News

More insights

November 11, 2024
What is the Difference Between MedTech and TechMed?  
Learn More
March 7, 2024
FDA Clears Dexcom’s First Over-the-Counter Continuous Glucose Monitor
Learn More
March 1, 2024
FDA greenlights Boston Scientific’s Novel Drug-Coated Balloon for Coronary In-Stent Restenosis
Learn More

Begin your legacy now. We are your medtech and medical device talent advisory firm.